# VitaGen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vitagen

- Industry: Biotechnology
- Headquarters: US
- Total disclosed funding: $14M
- Latest round: Series C (Jun 1, 2001)
- Investors on record: 12

## About

VitaGen, Inc. is a biotechnology company focused on developing an artificial liver that would be used until a transplant is performed.

## Funding rounds

- Series C, Jun 1, 2001, $14M — Alta Partners, Essex Woodlands, Pacific Horizon Ventures, Tullis Health Investors, Triad Ventures, Perseus, Radius Ventures, BD Ventures, Paragon Partners, JP Morgan Asset Management, Merrill Lynch Ventures, BCM Technologies

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C
- Essex Woodlands (https://capitalatlas.ai/funds/essex-woodlands) — Series C
- Pacific Horizon Ventures (https://capitalatlas.ai/funds/pacific-horizon-ventures) — Series C
- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series C
- Triad Ventures (https://capitalatlas.ai/funds/triad-ventures) — Series C
- Perseus (https://capitalatlas.ai/funds/perseus) — Series C
- Radius Ventures (https://capitalatlas.ai/funds/radius-ventures) — Series C
- BD Ventures (https://capitalatlas.ai/funds/bd-ventures) — Series C
- Paragon Partners — Series C
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series C
- Merrill Lynch Ventures — Series C
- BCM Technologies — Series C